Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pathology Watch
AddedFeb 15, 2024
UpdatedJun 18, 2026
Pathology Watch

Pathology Watch

Series D

Pathology Watch offers a user-friendly digital pathology solution for dermatologists.

HQ
Murray, UT, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Pathology Watch, founded with the mission to revolutionize dermatopathology, offers a user-friendly digital pathology solution tailored for dermatologists. The company aims to enhance patient outcomes by integrating advanced digital tools into dermatological practices, streamlining workflows, and improving diagnostic accuracy. Their primary product is a comprehensive digital pathology platform that seamlessly interfaces with electronic medical records (EMR), allowing for efficient and precise pathology services.

Notable affiliated individuals include Dr. Kelly Stankiewicz, Dr. Jeffrey R. Smith, and Dr. Jesse Jensen, who have endorsed the platform for its operational efficiency and utility in patient communication. Pathology Watch has achieved significant milestones in improving practice efficiency and patient care through its innovative digital solutions. The company's impact is evident in the enhanced operational workflows and improved diagnostic capabilities experienced by its users, positioning it as a leader in digital dermatopathology.

Pathology Watch - Similar Companies

PathologyWatch logo

PathologyWatch

Pramana logo

Pramana

pramana.ai

HistoWiz logo

HistoWiz

histowiz.com

Gestalt Diagnostics logo

Gestalt Diagnostics

NeuroPath logo

NeuroPath

neuropath.life

VistaPath Biosystems logo

VistaPath Biosystems

vistapath.ai

4D Path logo

4D Path

4dpath.com

Ad Path Labs logo

Ad Path Labs

rebiz.com

Proscia logo

Proscia

proscia.com

Alexapath logo

Alexapath

alexapath.com

Pictor Labs logo

Pictor Labs

Direct Dermatology logo

Direct Dermatology

directderm.com

Instapath Inc. logo

Instapath Inc.

instapathbio.com

PathGroup logo

PathGroup

FirstDerm logo

FirstDerm

firstderm.com

Pathology Watch - Quick Facts

Who are Pathology Watch's competitors?

Companies similar to Pathology Watch include PathologyWatch, Pramana, HistoWiz and Gestalt Diagnostics.

When was Pathology Watch founded?

Pathology Watch was founded in 2018.

Where is Pathology Watch's headquarters located?

Pathology Watch's headquarters is located in Murray, UT, US.

How much has Pathology Watch raised to-date?

As of Apr 18, 2023, Pathology Watch has raised a total of $56.7M (USD).

How many employees does Pathology Watch have?

Pathology Watch has 66 employees as of Feb 5, 2024.

Pathology Watch - Classification

Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Digital Pathology
Tags
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 623000Nursing and Residential Care Facilities
SIC
  • 8060Hospitals